SciSparc Ltd. (NASDAQ: SPRC) Uplists To NASDAQ, Full Pipeline Of Clinical Trials Set For 2022

January 3, 2022

SciSparc Ltd. (NASDAQ: SPRC) began trading on the NASDAQ last month. It is a clinical stage pharmaceutical company with multiple catalysts. It has clinical trials set this year for its proprietary drug candidates. This Tel Aviv-based Company has a full portfolio of patented treatments and therapies focused on the central nervous system. It applies unique technologies through non-psychoactive cannabinoid ‘CBD’ pharmaceuticals. Its leading drug candidate SCI:110 is entering the clinical…

Read More >>